Good candidates Younger patients (late 20s to mid 30s) seeking preventive treatment to soften early dynamic lines and slow the formation of static lines Mid-life patients (mid 30s to mid 50s) with established dynamic lines wanting smoother appearance typically the largest patient cohort Older patients (50+) using anti wrinkle injections as one part of combination treatment alongside dermal fillers, biostimulators, or surgical rejuvenation Patients with bruxism / jaw clenching / TMJ pain masseter injection (see jaw slimming) Patients with chronic migraine (15+ headache days per month) see migraine treatment Patients with axillary hyperhidrosis see anti sweat injections Men increasingly common patients
Wegovy is typically prescribed for people who are looking for an effective obesity treatment and is recommended for individuals with a body mass index (BMI) of 27 or higher and who have at least one weight-related condition, such as high blood pressure, Type 2 diabetes, or high cholesterol, according to the drugs Health Canada approval statement
10.3389/fnins.2019.00085 34 Del ReD
Those fats remain trapped in liver cells, impairing metabolic function and creating the inflammatory environment that promotes insulin resistance
These changes typically resolve within 23 months as the body adapts to both the drug and the new weight set point, though individual timelines vary
